Advertisement
Screener

INOGEN, INC. (INGN) Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3

2.1 / 5 stars · 51/120 Roast Me

INOGEN, INC. Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3

INOGEN, INC. (INGN) reported Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3 of $76.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2016-03-14.

Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3 · last filed 2016-03-14

  • INOGEN, INC. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, transfers out of level 3 for the quarter ending 2014-12-31 was $0.00.
  • INOGEN, INC. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, transfers out of level 3 for the quarter ending 2014-09-30 was $0.00.
  • INOGEN, INC. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, transfers out of level 3 for the quarter ending 2014-06-30 was $0.00.
  • INOGEN, INC. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, transfers out of level 3 for the quarter ending 2014-03-31 was $76.00K.
  • INOGEN, INC. fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, transfers out of level 3 for fiscal 2014 was $76.00K.
Period endFair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3 3 monthFair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3 6 monthFair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3 9 monthFair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Transfers out of Level 3 12 month
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
$0.00
derived: sum of 2 quarters · filed 2016-03-14
$0.00
derived: sum of 3 quarters · filed 2016-03-14
$76.00K
10-K · filed 2016-03-14
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
$0.00
derived: sum of 2 quarters · filed 2014-11-12
$76.00K
10-Q · filed 2014-11-12
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$76.00K
10-Q · filed 2014-08-12
2014-03-31$76.00K
10-Q · filed 2014-05-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B